The effect of Omega-3 supplementation in Covid-19
Not Applicable
Recruiting
- Conditions
- Covid-19.
- Registration Number
- IRCT20210522051363N1
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Being 20 to 65 years old
Detection of COVID-19 based on PCR test
Willingness to participate in the study
Covid 19 patients without underlying disease (in consultation with the consultant)
Exclusion Criteria
Breastfeeding and pregnancy
Advanced respiratory distress syndrome leading to intubation
Patients with coagulation disorders
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum levels of interleukin-6. Timepoint: Beginning and end of the study. Method of measurement: Blood test.;Serum levels of blood cells. Timepoint: Beginning and end of the study. Method of measurement: Blood test.;Serum levels of reactive protein-C. Timepoint: Beginning and end of the study. Method of measurement: Blood test.;Serum levels of erythrocyte sedimentation rate. Timepoint: Beginning and end of the study. Method of measurement: Blood test.
- Secondary Outcome Measures
Name Time Method